ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,306.04
0.02%
Dow Jones
38,852.86
-0.55%
US Dollar vs MXN
16.75385
-0.25%
Brent Oil
84.63
0.36%
Bitcoin
67,863.79
-0.63%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. NGM Biopharmaceuticals Inc (NGM)

  7. NGM Biopharmaceuticals Inc (NGM) Noticias

NGM NGM Biopharmaceuticals Inc

1.54
0.00 (0.00%)
Pre Mercado
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
NGM Biopharmaceuticals Inc NGM NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 1.54 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.54
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
05/4/202408:19GLOBENGM Bio Announces Closing of Tender Offer
19/3/202416:30GLOBENGM Bio to Present Two Posters Highlighting Clinical Data..
11/3/202415:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/3/202415:13EDGAR2Form 8-K - Current report
11/3/202415:05GLOBENGM Bio Provides Recent Business Highlights and Reports..
08/3/202416:32EDGAR2Form SC 13E3 - Going private transaction by certain issuers
08/3/202416:21EDGAR2Form SC 14D9 - Solicitation, recommendation statements
26/2/202416:11EDGAR2Form SC14D9C - Written communication relating to third party..
26/2/202416:01EDGAR2Form 8-K - Current report
26/2/202408:03GLOBENGM Bio Has Entered into a Definitive Agreement and Plan of..
20/2/202415:01GLOBENGM Bio to Participate in the Cowen 44th Annual Health Care..
14/2/202417:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/1/202405:09EDGAR2Form 8-K - Current report
18/1/202417:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202417:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202415:47GLOBENGM Bio to Participate in the B. Riley Securities 4th Annual..
09/1/202407:00GLOBENGM Bio Announces New Clinical Data from Ongoing Trial of..
02/1/202406:30EDGAR2Form 8-K - Current report
04/12/202316:19EDGAR2Form 8-K - Current report
04/12/202315:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202308:45GLOBENGM Bio Presents Positive Phase 2b Results from the ALPINE 4..
08/11/202317:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/11/202317:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202317:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202317:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202315:05GLOBENGM Bio to Participate in Upcoming Investor Conferences
02/11/202315:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202315:06EDGAR2Form 8-K - Current report
02/11/202315:01GLOBENGM Bio Reports Third Quarter 2023 Financial Results and..
17/10/202316:28EDGAR2Form 8-K - Current report
11/10/202315:05GLOBENGM Bio Announces Oral Plenary Presentation of Data from..
27/9/202307:30PRNUSAlexandria Real Estate Equities, Inc.'s One-of-a-Kind,..
11/9/202315:01EDGAR2Form 8-K/A - Current report: [Amend]
11/8/202315:08EDGAR2Form 8-K - Current report
06/8/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
04/8/202316:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/8/202315:01EDGAR2Form S-3/A - Registration statement under Securities Act of..
03/8/202315:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202315:07EDGAR2Form 8-K - Current report
03/8/202315:01GLOBENGM Bio Reports Second Quarter 2023 Financial Results and..

Su Consulta Reciente

NASDAQ
NGM
NGM Biopharmaceuticals
LSE
JU66
Citi Fun 26
COIN
MSWAPETH
MoneySwap
BIT
P1SBR5
NLBNPIT1SBR5 20241220 20
UNSW3
GOLETH
GOGOLCOIN
COIN
XMARKETH
Standard on xDai on BSC
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados